Scroll to the top

{{ subpage.title }}

The Parthenon Marbles dispute and the debate over cultural repatriation
The Parthenon Marbles dispute and the debate over cultural repatriation | GZERO World

The Parthenon Marbles dispute and the debate over cultural repatriation

Who gets to claim art as their own? It’s a complicated issue, and elite art institutions are undergoing a reckoning over their Indiana Jones-style acquisition tactics of the past. GZERO’s Alex Kliment explores the complex debate of art repatriation and the controversy surrounding ancient artifacts displayed in Western museums. One of the most infamous cases involves the Parthenon Marbles (sometimes called the Elgin Marbles) at the British Museum, which the British took during Ottoman rule. The Greeks have been demanding the Marbles be returned for almost 200 years.

“I think this is really a moral or ethical case,” says Leila Amineddoleh, an art repatriation expert, “Should museums hold onto objects that were taken under either violent circumstances or were taken during a time of looting, theft or when a country was colonized?”

Read moreShow less

Hump day recommendations, Jan. 17, 2024

Visit: “Anyang” at the Smithsonian National Museum of Asian Art. This is the first major exhibition in the United States about the artistic and archaeological wonders found in China’s oldest imperial capital. The exhibit features some of the earliest samples of writing in human history, the so-called “Oracle Bone” characters etched into the belly bones of ancient tortoises, then cracked with red-hot irons to reveal the will of Shangdi. You’ll be amazed by the intricate bronzewares, covered in multimorphic animal motifs that shift with your perspective. My favorite? One of the earliest known depictions of a dragon, wrapping its serpentine body around a wide bowl. – Matt

Watch: "American Fiction." This poignant, hilarious satire is a deeply layered examination of race in the US and how narratives surrounding it are both shaped and perceived. Jeffrey Wright is fantastic as the lead character, Monk, a smug, grumpy novelist who has his world – and his assumptions about people – turned upside down as the film progresses. Highly recommend checking this out in theaters! – John

Listen/Read: “The Price of Netanyahu’s Ambition,” by David Remnick. I listened to this hour-long portrait of who Netanyahu is to Israelis and to himself in the aftermath of Oct. 7. I thought it painted a great picture of the political and media landscape in Israel right now and in the not-so-distant past. – Riley

Fight: Tyranny. Most conservatives who worry about “tyranny” seem to have in mind the supposedly coercive overreach of the government. But as the prominent arch-conservative Catholic writer Sohrab Ahmari sees it, the vast majority of the coercion that Americans experience in their daily lives actually comes from the private sector. In his book, “Tyranny, Inc.,” he argues that the court-backed power of employers, the massive privatization of public services, and the cult of deregulation have left Americans at the mercy of a new market-powered tyrant. Amazingly for a conservative, he ends up prescribing a revived New Deal to keep the playing field even. If nothing else, a bold attempt to break stereotypes of left and right — see if you find it compelling. – Alex
US bet on Pfizer and Moderna may lead to earlier COVID vaccine rollout
US Bet On Pfizer and Moderna May Lead to Earlier COVID Vaccine Rollout | World In :60 | GZERO Media

US bet on Pfizer and Moderna may lead to earlier COVID vaccine rollout

Ian Bremmer shares his perspective on global politics on this week's World In (More Than) 60 Seconds:

With COVID vaccine near, what will the distribution look like across the world?

Well, yeah, it is quite near. I mean, we're talking about approvals coming just in the next few days for the first in the United States and indeed in other countries around the world. That means that within weeks, you're going to know people that have actually gotten vaccines, and that's pretty exciting, especially with Moderna and Pfizer showing 95% effectiveness. I guess there are a few things that I would say. The first, hearing from the coronavirus task force that everyone in the United States gets the vaccine that wants to take it by June. I think that's right. I mean, there could be infrastructure and delivery hiccups. I hope there won't be. Everyone is going to be rowing in more or less the same direction on this because everyone understands how important it is to get it done.

Read moreShow less

Subscribe to our free newsletter, GZERO Daily